title: Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment.
authors.forename: Markus P
authors.initials: MP
authors.lastname: Schlaich
authors.forename: Elisabeth A
authors.initials: EA
authors.lastname: Lambert
authors.forename: Paul A
authors.initials: PA
authors.lastname: Sobotka
authors.forename: Gavin W
authors.initials: GW
authors.lastname: Lambert
authors.forename: Murray D
authors.initials: MD
authors.lastname: Esler
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002908:Chronic Disease; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy*; D007674:Kidney Diseases / Q000209:etiology* / Q000503:physiopathology*; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors